Sareum is Biotechnology in United Kingdom that focus on drug programs business. Founded in 2003. They cover business area such as Sareum Holdings PLC, drug discovery, development, cancer, autoimmune disease, pharmaceutical and biotechnology company, Checkpoint Kinase, Tyrosine, potency, disease model, combination, chemotherapy, acute myeloid leukemia, AML, b-cell lymphoma, radiotherapy, a series, various autoimmune and inflammatory disorder.
2003
( 21 years old in 2024 )
Drug Programs
-
Unit 2A, Langford Arch
London Road, Pampisford
Cambridge CB22 3FX
England, United Kingdom
Private
Sareum Holdings PLCdrug discoverydevelopmentcancerautoimmune diseasepharmaceutical and biotechnology companyCheckpoint KinaseTyrosinepotencydisease modelcombinationchemotherapyacute myeloid leukemiaAMLb-cell lymphomaradiotherapya seriesvarious autoimmune and inflammatory disorder
* We use standard office opening hours in near Sareum's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Sareum is Biotechnology business from United Kingdom that founded in 2003 (21 years old in 2024), Sareum business is focusing on Drug Programs.
Sareum headquarter office and corporate office address is located in Unit 2A, Langford Arch London Road, Pampisford Cambridge CB22 3FX England, United Kingdom.
Sareum was founded in United Kingdom.
In 2024, Sareum is currently focus on drug programs sector.
Above is snippet of Google Trends for "drug programs" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Sareum, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
